Meet our team to explore how RetinAI Discovery’s advanced GA segmentation can enhance your clinical trials and real-world evidence projects.
Book a meeting with usFebruary 12-15
Charlotte Harbor, FL
Schedule a meeting with us!
RetinAI Discovery is set to revolutionize the management and research of retinal diseases with its advanced AI-driven analytics platform. Leveraging cutting-edge technology, Discovery offers a comprehensive suite of tools for the detailed analysis of retinal imaging, enabling the early detection, accurate diagnosis, and effective monitoring of conditions like AMD, GA, DR, DME, and more.
Join us at the Macula Society Annual Meeting to network with our team and see the full capabilities of the Discovery platform and how it's facilitating breakthroughs in personalized patient care and advanced retinal research.
We would be pleased to connect with you before the meeting!
Dr Carlos Ciller, Co-Founder & CEO
Natasa Jovic, VP of Marketing Strategy & Research Partnerships
Aunia Grogan, VP of Business Development
Feb. 14
🗣 Presented by Dr. Baruch D. Kuppermann, MD, PhD Steinert Endowed Professor and Chair, Department of Ophthalmology; Director, UCI Gavin Herbert Eye Institute
🕐 2:25 to 2:30PM
📍Session Artificial Intelligence I at the Great Egret Ballroom
✍🏻 Dr. Baruch D. Kuppermann MD, PhD, Dr. Joseph Blair, Dr. Sandro De Zanet, Dr. Stefanos Apostolopoulos, Dr. Carlos Ciller, Dr. Lori Huang PharmD, MBA, Dr. David N. Zacks MD, PhD
🗣 Presented by Dr. Aude Ambresin MD, PD, Swiss Visio Lausanne Switzerland
🕐 2:35 to 2:40PM
📍Session Basic Science and AI II at the Great Egret Ballroom
✍🏻 Dr. Aude Ambresin MD, PD, Mrs. Mihaela Chitoroaga, Mr. Nicolo Bartolomeo, Mr. Pathé Barry Mamadou, Mrs. Yannic A. Pannatier, Mrs. Daniela A. Gallo, Mrs. Anna A. Nascimbenis